# P2-B Risk Mitigation Plan

**Horizon:** 1 (Architecture Foundation Framework)  
**Phase:** P2-B (Provider Integration & Architecture Validation)  
**Document Type:** Risk Mitigation Plan  
**Date:** 2026-07-11  
**Authority:** Chief Architect

---

## Purpose

This plan defines **identified risks for P2-B** and their mitigation strategies.

**Critical Principle:**

> **Architecture validation depends on high-quality, independent, and reproducible evidence.**

---

## Risk Summary

**Total Risks:** 4

| Risk ID | Risk Title | Impact | Status |
|---------|-----------|---------|--------|
| RISK-1 | Evidence Quality | High | Mitigated |
| RISK-2 | ADR Traceability | Medium | Mitigated |
| RISK-3 | Evidence Accumulation | Medium | Mitigated |
| RISK-4 | Evidence Independence | High | Mitigated |

---

## RISK-1: Evidence Quality

### Risk Description

**Problem:**

> If evidence quality is not classified, architectural verdicts may depend on weak evidence (e.g., manual observation without reproducibility).

**Consequence:**

- Low-confidence verdicts
- Architecture Assessment cannot validate Stage 1.0
- Post-P2-B decisions based on unreliable evidence

**Impact:** High

**Likelihood:** High (without mitigation)

---

### Mitigation Strategy

**Solution:** Evidence Quality Framework

**Implementation:**

Create `00-EVIDENCE-QUALITY-FRAMEWORK.md`:

- Define **4 quality levels** (L1 Observational → L4 Adversarial)
- Require **L3+ evidence** for high-confidence verdicts
- Label all evidence artifacts with quality level
- Define **9 acceptance criteria questions** for every evidence artifact

**Location:** `.ai/reviews/horizon-1/p2-b-evidence/00-EVIDENCE-QUALITY-FRAMEWORK.md`

**Status:** ✅ **IMPLEMENTED** (2026-07-11)

---

### Acceptance Criteria

- [ ] Evidence Quality Framework created
- [ ] 4 quality levels defined (L1, L2, L3, L4)
- [ ] Verdict confidence matrix defined (L1 → Low, L3+ → High)
- [ ] Evidence labeling standard defined
- [ ] All evidence artifacts labeled with quality level during P2-B
- [ ] No high-confidence verdict based on L1/L2 evidence only

---

## RISK-2: ADR Traceability

### Risk Description

**Problem:**

> If evidence is not traceable to ADRs and success criteria, it is unclear which architectural claims are validated.

**Consequence:**

- Evidence exists but purpose unclear
- Architecture Assessment cannot validate specific architectural decisions
- Gap between "what was tested" and "what was decided"

**Impact:** Medium

**Likelihood:** Medium (without mitigation)

---

### Mitigation Strategy

**Solution:** ADR Traceability Matrix

**Implementation:**

Create `02-ADR-TRACEABILITY-MATRIX.md`:

- Map **every ADR → Evidence artifacts**
- Map **every Success Criteria → Evidence artifacts**
- Map **every Quality Attribute → Evidence artifacts**
- Ensure **bidirectional traceability**

**Location:** `.ai/reviews/horizon-1/p2-b-evidence/02-ADR-TRACEABILITY-MATRIX.md`

**Status:** ✅ **IMPLEMENTED** (2026-07-11)

---

### Acceptance Criteria

- [ ] ADR Traceability Matrix created
- [ ] All P0 ADRs (ADR-1001, ADR-1006, ADR-1050, ADR-1053) mapped to evidence
- [ ] All P1 ADRs mapped to evidence (as written)
- [ ] All Success Criteria mapped to evidence
- [ ] All Quality Attributes mapped to evidence
- [ ] Bidirectional traceability verified (ADR → Evidence, Evidence → ADR)

---

## RISK-3: Evidence Accumulation

### Risk Description

**Problem:**

> If evidence accumulates without organization, P2-B Evidence Package becomes unmanageable and unreviewable.

**Consequence:**

- Evidence exists but cannot be found
- Duplicate evidence artifacts
- Inconsistent naming/structure
- Architecture Assessment blocked by disorganized evidence

**Impact:** Medium

**Likelihood:** High (without mitigation)

---

### Mitigation Strategy

**Solution:** Incremental Evidence Assembly

**Implementation:**

Structure `.ai/reviews/horizon-1/p2-b-evidence/` directory:

- **00-EVIDENCE-QUALITY-FRAMEWORK.md** (classification standards)
- **01-ISSUE-CLASSIFICATION-FRAMEWORK.md** (Issue/Limitation/Debt)
- **02-ADR-TRACEABILITY-MATRIX.md** (ADR → Evidence mapping)
- **03-EVIDENCE-INDEX.md** (master index of all evidence artifacts)
- **ARCHITECTURE-DEBT-REGISTER.md** (debt tracking)
- **evidence/** (subdirectory for evidence artifacts)
  - `EVD-001-L3-provider-swap-test.md`
  - `EVD-002-L3-ci-pipeline-green.md`
  - `EVD-003-L2-deployment-validation.md`
  - etc.

**Naming Convention:**

```
EVD-<id>-<quality-level>-<short-description>.md

Example:
EVD-001-L3-provider-swap-test.md
```

**Location:** `.ai/reviews/horizon-1/p2-b-evidence/`

**Status:** ✅ **IMPLEMENTED** (2026-07-11)

---

### Acceptance Criteria

- [ ] Evidence directory structure created
- [ ] Evidence naming convention defined
- [ ] Evidence Index created (03-EVIDENCE-INDEX.md)
- [ ] All evidence artifacts follow naming convention
- [ ] Evidence Index updated incrementally during P2-B
- [ ] No duplicate evidence artifacts

---

## RISK-4: Evidence Independence

### Risk Description

**Problem:**

> If implementation, evidence, and review are all created by the same pipeline or team without cross-checking, evidence may only show what the implementer intended to show, lacking independent validation.

**Consequence:**

- Evidence lacks independence
- Confirmation bias (evidence confirms what implementer believes)
- Architectural claims cannot be verified by independent reviewer
- Architecture Assessment lacks objectivity

**Impact:** High

**Likelihood:** Medium (without mitigation)

---

### Mitigation Strategy

**Solution:** Evidence Independence Protocol

**Implementation:**

1. **Separate Evidence from Implementation**
   - Implementation code: `src/`
   - Test code: `tests/`
   - Evidence artifacts: `.ai/reviews/horizon-1/p2-b-evidence/evidence/`
   - Review artifacts: `.ai/reviews/horizon-1/p2-b-evidence/reviews/`

2. **Evidence MUST Reference Primary Sources**
   - Test logs (CI/CD pipeline)
   - Deployment logs (production environment)
   - Trace logs (observability system)
   - Code diffs (Git commits)
   - **NOT implementation author's summary**

3. **Independent Review Required for Critical Claims**
   - L4 evidence requires independent reviewer (not implementer)
   - Architecture Assessment requires independent review of Evidence Package
   - Critical architectural claims require L3+ evidence + independent review

4. **Document Assumptions and Limitations**
   - Every evidence artifact MUST document:
     - What was tested (scope)
     - What was NOT tested (limitations)
     - Assumptions made during testing
   - This allows independent reviewer to assess evidence validity

5. **Reproducibility Standard**
   - Every evidence artifact MUST be reproducible by independent reviewer
   - Reproduction steps MUST be documented
   - Configuration MUST be documented
   - Commit hash MUST be documented

**Status:** ✅ **DEFINED** (2026-07-11)

---

### Acceptance Criteria

- [ ] Evidence artifacts separated from implementation code
- [ ] Evidence artifacts reference primary sources (logs, traces, diffs)
- [ ] Independent review required for L4 evidence
- [ ] Independent review required for Architecture Assessment
- [ ] All evidence artifacts document assumptions and limitations
- [ ] All evidence artifacts are reproducible by independent reviewer
- [ ] Evidence Package reviewable by someone who did not implement P2-B

---

### Evidence Review Checklist (Independent Reviewer)

**Before accepting evidence as valid:**

- [ ] Evidence references primary sources (not just author summary)
- [ ] Evidence assumptions documented
- [ ] Evidence limitations documented
- [ ] Evidence reproducible (reproduction steps + commit + config)
- [ ] Evidence quality level justified
- [ ] Evidence traceable to ADR/Success Criteria/Quality Attribute
- [ ] Evidence free from obvious confirmation bias

**Reviewer Authority:**

- Chief Architect (final approval)
- Independent Reviewer (for L4 evidence)
- Engineering Lead (for L3 evidence)

---

## Risk Mitigation Timeline

| Risk | Mitigation | Implementation Date | Review Date |
|------|-----------|---------------------|-------------|
| RISK-1 | Evidence Quality Framework | 2026-07-11 | P2-B completion |
| RISK-2 | ADR Traceability Matrix | 2026-07-11 | P2-B completion |
| RISK-3 | Incremental Evidence Assembly | 2026-07-11 | P2-B completion |
| RISK-4 | Evidence Independence Protocol | 2026-07-11 | P2-B completion |

---

## Risk Review Process

**Frequency:** Weekly during P2-B implementation

**Review Questions:**

1. Are any mitigated risks re-emerging?
2. Are any new risks discovered?
3. Are mitigation strategies working?
4. Are acceptance criteria being met?

**Review Authority:**

- Chief Architect (risk owner)
- Engineering Lead (implementation review)
- Independent Reviewer (evidence review)

---

## Anti-Patterns

### ❌ Anti-Pattern 1: Low-Quality Evidence Accepted

**Example:**

> "Provider abstraction is production-ready."
> 
> Evidence: L1 (manual observation)

**Why Wrong:**

- High-impact claim requires L3+ evidence
- Manual observation not reproducible

**Mitigation:**

- Reject L1/L2 evidence for high-confidence verdicts
- Require L3+ evidence for all critical architectural claims

---

### ❌ Anti-Pattern 2: Evidence Without Traceability

**Example:**

> "Test suite passed."

**Why Wrong:**

- No trace to architectural claim
- No trace to ADR or success criteria

**Mitigation:**

- Require traceability matrix
- Reject evidence without ADR/Success Criteria reference

---

### ❌ Anti-Pattern 3: Evidence Without Reproducibility

**Example:**

> "Test passed on my machine."

**Why Wrong:**

- Not reproducible by others
- No commit hash, no configuration, no environment

**Mitigation:**

- Require 9 acceptance criteria questions answered
- Require reproduction steps documented

---

### ❌ Anti-Pattern 4: Self-Review Only

**Example:**

> "I implemented it, I tested it, I reviewed it, it's done."

**Why Wrong:**

- Lack of independent validation
- Confirmation bias risk
- Evidence may only show what implementer intended

**Mitigation:**

- Require independent review for L4 evidence
- Require independent review for Architecture Assessment
- Separate evidence artifacts from implementation code

---

## Summary

**P2-B Risk Mitigation:**

1. **RISK-1 (Evidence Quality):** Mitigated via Evidence Quality Framework (L1-L4)
2. **RISK-2 (ADR Traceability):** Mitigated via ADR Traceability Matrix
3. **RISK-3 (Evidence Accumulation):** Mitigated via Incremental Evidence Assembly
4. **RISK-4 (Evidence Independence):** Mitigated via Evidence Independence Protocol

**Outcome:**

> If P2-B follows these mitigation strategies, Architecture Assessment can produce high-confidence, independent, reproducible verdict on Stage 1.0 validity.

---

**Document Version:** 1.0 (FINAL)  
**Date:** 2026-07-11  
**Status:** Active Risk Mitigation Plan  
**Authority:** Chief Architect  
**Cross-Reference:** 00-EVIDENCE-QUALITY-FRAMEWORK.md, 01-ISSUE-CLASSIFICATION-FRAMEWORK.md, 02-ADR-TRACEABILITY-MATRIX.md, 03-EVIDENCE-INDEX.md
